Former KL2 Scholar, Josephine Taverna, MD, associate professor in the Department of Molecular Medicine and the Division of Hematology and Oncology, Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, received her  V Foundation grant for her proposal to investigate checkpoint inhibitors for lung cancer treatment that can block cancer signaling within tumor habitats to halt growth, treatment resistance and metastasis. Taverna received the “A Grant of Her Own: The Women Scientists Innovation Award” Translational Research grant, one of only six recipients in the United States to earn the $800,000, four-year grant.

Click here to read more.